Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TaiGen Biopharmaceuticals Holdings Limited (4157) Income Statement

TaiGen Biopharmaceuticals Holdings Limited Income Statement

Last quarter (Q2 2026), TaiGen Biopharmaceuticals Holdings Limited's total revenue was NT$8.23M, a decrease of 23.14% from the same quarter last year. In Q2, TaiGen Biopharmaceuticals Holdings Limited's net income was NT$-21.28M. See TaiGen Biopharmaceuticals Holdings Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 259.47MNT$ 150.65MNT$ 123.13MNT$ 36.23MNT$ 1.29B
NT$ 223.83MNT$ 134.52MNT$ 111.69MNT$ 32.49MNT$ 1.28B
NT$ 154.43MNT$ 256.62MNT$ 258.78MNT$ 310.16MNT$ 382.34M
Depreciation and AmortizationNT$ 17.47MNT$ 24.83MNT$ 27.61MNT$ 28.55MNT$ 28.86M
NT$ 86.87MNT$ -6.63MNT$ 172.23MNT$ -200.37MNT$ 928.34M
NT$ 69.39MNT$ -122.10MNT$ -174.70MNT$ -217.15MNT$ 876.24M
NT$ -11.95MNT$ 89.21MNT$ 318.19MNT$ 47.91MNT$ -23.47M
NT$ 57.44MNT$ -32.88MNT$ 143.49MNT$ -229.76MNT$ 875.99M
NT$ 45.18MNT$ -38.58MNT$ 136.73MNT$ -237.16MNT$ 775.62M
Per Share Metrics
Basic EPSNT$ 0.06NT$ -0.05NT$ 0.19NT$ -0.33NT$ 1.08
Diluted EPSNT$ 0.06NT$ -0.05NT$ 0.19NT$ -0.33NT$ 1.08
Weighted Average Shares Outstanding715.92M717.48M717.27M716.84M716.84M
Weighted Average Shares Outstanding (Diluted)716.11M717.48M717.27M716.84M717.36M

Currency in TWD

TaiGen Biopharmaceuticals Holdings Limited Earnings and Revenue History

-800M0800M1.6B-2000 %-1000 %0 %1000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin